
Wall Street institutions, including Goldman Sachs and Citadel Securities, are advising clients to purchase cheap hedging tools, such as August and September put options, despite the S&P 500's 28% rally and the VIX at multi-month lows. This proactive stance is driven by a confluence of approaching risk events, notably the Federal Reserve's interest rate decision, the deadline for Trump's tariffs, and critical tech earnings, with hedge costs currently at their lowest since January. The consensus reflects institutional concerns about the market's elevated levels and historical September weakness, offering an opportunity to "rent hedging tools" affordably.
Despite the S&P 500 Index having rallied 28% since April 8 and the VIX Index falling to its lowest level since February, a strong consensus has emerged among major Wall Street dealers to hedge against imminent downside risk. Institutions including Goldman Sachs, Citadel Securities, Bank of America, and JPMorgan are advising clients to purchase protection, citing a dense calendar of risk events such as the Federal Reserve's July 30 interest rate decision, upcoming tariff deadlines, and critical earnings reports from technology leaders like NVIDIA. The core of this recommendation is a tactical opportunity: the cost of hedging, as measured by options on S&P 500 ETFs, has fallen to its lowest point since January, making it inexpensive to "rent hedging tools." This advice is further supported by historical precedent, with Citadel Securities noting that September has been the worst-performing month for U.S. stocks since 1928. While some strategists acknowledge that retail flows or a dovish Fed could extend the rally, the prevailing institutional sentiment is decidedly cautious, reflecting concern that the market is operating at elevated levels and is vulnerable to the upcoming macro catalysts.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment